Fierce Pharma February 3, 2023
By Max Bayer, Fraiser Kansteiner

J&J’s pharmaceutical changes come as the company spins off its consumer healthcare group into a separate company called Kenvue. (BSR Agency/Getty Images News)

Three Johnson & Johnson pharmaceutical executives stood before a group of staff in the R&D unit Wednesday, joking about expensive Uber rides and one “phenomenal dinner” at a Japanese steakhouse while attending the J.P. Morgan Healthcare Conference in San Francisco in early January.

But just minutes earlier, the mood was anything but jovial, as the leaders explained to a nervous group of employees in the Janssen pharmaceutical unit an overhaul of operations for the infectious diseases and vaccine groups, with sweeping layoffs expected to claim staffers’ jobs in countries around the world. Some staff...

Today's Sponsors


Today's Sponsor


Topics: Biotechnology, Pharma, Pharma / Biotech
Venture fund spun out of GSK raises $600M to target healthcare
Vertex Pays CRISPR Therapeutics $100M to Bring Gene-Editing to Type 1 Diabetes
The Role of the Pharmacy Technician Expanded During the COVID-19 Pandemic
US spent $4.3 trillion on healthcare in 2021: Here's how
Amazon underestimated complexity of healthcare: Report

Share This Article